Antimicrobial effectiveness testing is intended to demonstrate that a product can control microbial growth over time. In practice, the challenge is not running the test, but ensuring that the results reflect true product performance rather than artifacts of the method.
Preservatives can suppress recovery during testing, neutralization may be incomplete, and borderline log reduction results are often difficult to interpret. Programs that rely solely on pass/fail outcomes miss these underlying issues.
We approach antimicrobial testing as a functional evaluation of product performance, not just a compendial requirement.
What We Test
We support antimicrobial effectiveness and functional testing programs for pharmaceutical and consumer products, including preserved multi-dose formulations, topical products, oral liquids, and materials with antimicrobial claims. Programs may be compendial (USP <51>) or designed to support formulation development, disinfectant qualification, and comparative performance studies.
Antimicrobial Effectiveness Testing
USP <51> defines challenge studies where products are inoculated with specified microorganisms and evaluated over time for log reduction. Acceptance criteria vary by product category and are based on reduction of bacterial and fungal populations across defined time points.
While the framework is straightforward, successful execution depends on accurate inoculum preparation, recovery of organisms, and effective neutralization of the product’s antimicrobial activity.
Method Suitability and Recovery
The most critical aspect of antimicrobial testing is ensuring that microorganisms can be recovered from the test system. Products with strong preservative systems may suppress recovery during plating, leading to results that appear compliant but are not representative.
We evaluate recovery at each stage of the study, confirming that neutralization is effective and that log reduction data reflects actual microbial kill rather than methodological suppression.
Disinfectant Efficacy Studies
Disinfectant efficacy testing evaluates the ability of disinfectants to control microbial contamination on surfaces and in controlled environments. These studies are typically performed in support of cleanroom environmental control programs and require demonstration of effectiveness against relevant organisms under defined conditions.
Performance depends on factors such as contact time, surface type, organism selection, and organic load. Inadequate study design can lead to disinfectants that appear effective in testing but fail in practice.
We design disinfectant studies that reflect actual use conditions, ensuring that selected agents perform reliably within the intended environment.
Admixture and Compatibility Studies
Admixture studies evaluate how antimicrobial systems perform when products are diluted, combined, or exposed to other materials during use. These conditions can alter preservative effectiveness, reduce antimicrobial activity, or introduce unexpected interactions.
We support admixture and compatibility studies to assess:
- preservative performance after dilution or mixing
- interaction with delivery systems or materials
- stability of antimicrobial function over time
These studies are particularly relevant for multi-dose products, compounded preparations, and products administered through devices or fluid pathways.
Program Design
Antimicrobial testing is often part of a broader formulation or lifecycle program. We support study design that considers product use conditions, reformulation risk, environmental controls, and stability expectations, ensuring that data generated is meaningful beyond a single test execution.
Standards and Regulatory Framework
Our antimicrobial testing programs are aligned with:
- USP <51> Antimicrobial Effectiveness Testing
- European Pharmacopoeia equivalent methods
- FDA expectations for preservative systems and disinfectant qualification
Start the Conversation
If your antimicrobial results are inconsistent, borderline, or difficult to interpret, we can help determine whether the issue is the formulation or the method.
